References

Citations

1. Ropper AH, Brown RH (2005). Multiple sclerosis and allied demyelinative diseases. In Adams and Victor's Principles of Neurology, 8th ed., pp. 771–796. New York: McGraw-Hill.

2. Bennett KA (2005). Pregnancy and multiple sclerosis. Clinical Obstetrics and Gynecology, 48(1): 38–47.

3. Giesser B (2003). Reproductive Issues in Persons With Multiple Sclerosis. Clinical Bulletin: Information for Health Professionals. New York: National Multiple Sclerosis Society.

4. Frohman EM (2003). Multiple sclerosis. Medical Clinics of North America, 87(4): 867–897.

5. McDonald WI, et al. (2001). Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Annals of Neurology, 50(1): 121–127.

6. Polman CH, et al. (2005). Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald Criteria. Annals of Neurology, 58(6): 840–846.

7. Sadiq SA (2005). Multiple sclerosis. In LP Rowland, ed., Merritt's Neurology, 11th ed., pp. 941–963. Philadelphia: Lippincott Williams and Wilkins.

8. Tintoré M (2003). New diagnostic criteria for multiple sclerosis: Application in first demyelinating episode. Neurology, 60(1): 27–30.

9. National Clinical Advisory Board of the National Multiple Sclerosis Society (2007). Disease Management Consensus Statement. New York: National Multiple Sclerosis Society. Available online: http://www.nationalmssociety.org/site/PageServer?pagename=HOM_PRO_expert_opinion_papers.

10. Lindsey JW, Wolinsky JS (2005). Demyelinating diseases. In DC Dale, DD Federman, eds., ACP Medicine, section 11, chap. 9. New York: WebMD.

11. Fassas A, et al., (2002). Hematopoietic stem cell transplantation for multiple sclerosis: A retrospective study. Journal of Neurology, 249(8): 1088–1097.

Other Works Consulted

• Yousry TA, et al. (2006). Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. New England Journal of Medicine, 354(9): 924–933.